PUBMED FOR HANDHELDS

Journal Abstract Search


604 related items for PubMed ID: 15334470

  • 1. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
    Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS.
    Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.
    Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
    [Abstract] [Full Text] [Related]

  • 3. Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine.
    Mok CC, Ho CT, Chan KW, Lau CS, Wong RW.
    Arthritis Rheum; 2002 Apr; 46(4):1003-13. PubMed ID: 11953978
    [Abstract] [Full Text] [Related]

  • 4. Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine.
    Mok CC, Ying KY, Yim CW, Ng WL, Wong WS.
    Lupus; 2009 Oct; 18(12):1091-5. PubMed ID: 19762384
    [Abstract] [Full Text] [Related]

  • 5. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [Abstract] [Full Text] [Related]

  • 6. Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens.
    Mok CC, Ho CT, Siu YP, Chan KW, Kwan TH, Lau CS, Wong RW, Au TC.
    Am J Kidney Dis; 2001 Aug; 38(2):256-64. PubMed ID: 11479150
    [Abstract] [Full Text] [Related]

  • 7. Urinary levels of RANTES and M-CSF are predictors of lupus nephritis flare.
    Tian S, Li J, Wang L, Liu T, Liu H, Cheng G, Liu D, Deng Y, Gou R, Wan Y, Jia J, Chen C.
    Inflamm Res; 2007 Jul; 56(7):304-10. PubMed ID: 17659436
    [Abstract] [Full Text] [Related]

  • 8. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [Abstract] [Full Text] [Related]

  • 9. Longterm followup of childhood lupus nephritis.
    Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, Eddy A, Gladman D, Urowitz M, Hebert D, Silverman E.
    J Rheumatol; 2002 Dec; 29(12):2635-42. PubMed ID: 12465165
    [Abstract] [Full Text] [Related]

  • 10. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [Abstract] [Full Text] [Related]

  • 11. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN.
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [Abstract] [Full Text] [Related]

  • 12. The long-term outcome of 93 patients with proliferative lupus nephritis.
    Moroni G, Quaglini S, Gallelli B, Banfi G, Messa P, Ponticelli C.
    Nephrol Dial Transplant; 2007 Sep; 22(9):2531-9. PubMed ID: 17510096
    [Abstract] [Full Text] [Related]

  • 13. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R, Palomba D, Satta A, Pirisi M, Tanda F, Bartoli E.
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [Abstract] [Full Text] [Related]

  • 14. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K, Yu Y, Tang Z, Liu Z, Li L.
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [Abstract] [Full Text] [Related]

  • 15. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C.
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [Abstract] [Full Text] [Related]

  • 16. Ovarian failure and flares of systemic lupus erythematosus.
    Mok CC, Wong RW, Lau CS.
    Arthritis Rheum; 1999 Jun; 42(6):1274-80. PubMed ID: 10366122
    [Abstract] [Full Text] [Related]

  • 17. Treatment and renal outcome of lupus nephritis: single center experience.
    Go KW, Teo SM.
    Med J Malaysia; 2006 Oct; 61(4):447-50. PubMed ID: 17243522
    [Abstract] [Full Text] [Related]

  • 18. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
    Arends S, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Berden JH, Dutch Working Party on systemic lupus erythematosus.
    Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
    [Abstract] [Full Text] [Related]

  • 19. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A, Radhakrishnan J, Estes D, D'Agati V, Kopelman R, Pernis A, Flis R, Pirani C, Appel GB.
    Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study.
    Wang S, Li X, Qu L, Wang R, Chen Y, Li Q, He X, Zhang X, Wang H, Wu J, Xu Y, Chen J.
    Lupus; 2012 Aug; 21(9):1025-35. PubMed ID: 22570338
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.